In addition, silencing APOL1 partly rescued the overexpression of NOP2-induced promotion of ccRCC progression, which highlighted the vital role of APOL1 in NOP2-driven ccRCC progression. The gene discussed is NOP2; the disease is nonpapillary renal cell carcinoma.